---
title: "US FDA gives approval to commercialise AI software to guide transcatheter procedures"
date: "2025-07-15T10:23:00.000Z"
publishedDate: "15 juillet 2025"
summary: "Caranx Medical has announced US Food and Drug Administration (FDA) clearance for the commercialisation of its artificial intelligence (AI) software for real-time intra-operative guidance of transcatheter heart valve (THV) implantation. The FDA clearance marks a significant milestone of Caranx&#8217;s strategy towards planned market introduction of TAVIPILOT Soft by the end of 2025, the company says [&#8230;] The post US FDA gives approval to commercialise AI software to guide transcatheter procedures appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-gives-approval-to-commercialise-ai-software-to-guide-transcatheter-procedures/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-15-us-fda-gives-approval-to-commercialise-ai-software-to-guide-transcatheter-procedures"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2016/07/tavi-durability-a-rose-by-any-other-name-is-still-a-rose-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-gives-approval-to-commercialise-ai-software-to-guide-transcatheter-procedures/"
---

![US FDA gives approval to commercialise AI software to guide transcatheter procedures](https://cardiovascularnews.com/wp-content/uploads/sites/14/2016/07/tavi-durability-a-rose-by-any-other-name-is-still-a-rose-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-gives-approval-to-commercialise-ai-software-to-guide-transcatheter-procedures/*

## L’essentiel

Caranx Medical has announced US Food and Drug Administration (FDA) clearance for the commercialisation of its artificial intelligence (AI) software for real-time intra-operative guidance of transcatheter heart valve (THV) implantation. The FDA clearance marks a significant milestone of Caranx&#8217;s strategy towards planned market introduction of TAVIPILOT Soft by the end of 2025, the company says [&#8230;] The post US FDA gives approval to commercialise AI software to guide transcatheter procedures appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/us-fda-gives-approval-to-commercialise-ai-software-to-guide-transcatheter-procedures/
